Distribution of expenses for research projects of Cancerfonden 2023, by type

Published by
Juliette Gagliardi,
May 24, 2024

The largest share of Cancerfonden's research expenses in 2023 was spent on translational research, and reached 52 percent. The second largest share of the research expenses was for pre-clinical research, and accounted for 32 percent of the expenses.

Cancerfonden is a Swedish independent non-profit foundation that aims to defeat cancer.

Distribution of expenses for research projects of Cancerfonden in 2023, by type

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2024

Region

Sweden

Survey time period

2023

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Cancer in Sweden "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Cancer in Sweden

Overview

4

Incidence

6

Survival rate

6

Treatment and care

5

Research and fundraising

5

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

Cancer in SwedenCancer in the U.S.Cancer worldwideCoronavirus (COVID-19) in Sweden Pharmaceutical industry in Sweden
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.